Skip to content
Download PDF

Emerging NeurotherapeuticTechnologies

Chapter 500 | Harrison's 22e · Parts 19-20 – Consultative & Emerging Topics · Chapter 500

Key Clinical Points

  1. Neurotherapeutic technologies aim to improve motor, sensory, and cognitive functions by harnessing neural plasticity.
  2. Robotics provide high-intensity training and quantitative feedback for stroke or brain injury recovery, potentially exceeding standard care.
  3. Augmented Reality (AR) can treat phantom limb pain by enabling 'phantom motor execution' via machine learning algorithms.
  4. Neurofeedback using real-time fMRI allows patients to train neural dynamics for chronic pain, Parkinson's disease, epilepsy, and ADHD.
  5. Noninvasive brain stimulation includes TMS (magnetic fields) and tDCS (electrical current).
  6. Brain-Machine Interfaces (BMI) allow 'locked-in' patients with ALS to bypass damaged motor pathways and communicate via computer systems.

DEFINITION & CLASSIFICATION

• Neurotherapeutic Technologies: A diverse group of promising treatment approaches designed to improve movement, sensory, and cognitive functions. ◦ Goal: Minimize the consequences of lost abilities (motor, sensory, or cognitive). ◦ Mechanism: Harness the inherent plasticity of the nervous system regardless of age or in the face of degenerative processes.

ETIOLOGY & PATHOPHYSIOLOGY

• Neural Plasticity: The primary biological principle underlying neurotherapeutic interventions. ◦ Activity-dependent plasticity: Mechanisms to maximize functional restoration. ◦ Motor Maps: The coordinated firing of neurons in remaining networks underlies observed functional improvements during rehabilitation. ◦ Clinical Application: Applicable to both 'static' conditions (e.g., stroke) and progressive neurologic disorders.

MANAGEMENT & TREATMENT

Robotics

• Purpose: Improve motor outcomes after stroke or other forms of brain injury. • Mechanism: ◦ High-intensity movement practice → can surpass what is possible via existing standards of care. ◦ Quantitative feedback: Systems precisely measure movement parameters (e.g., kinematics) and provide data on performance changes. ◦ Engagement: Focus on reward pathways to drive neural plasticity. • Features: ◦ Antigravity support: Allows practice and task engagement even in the presence of severe weakness. ◦ Clinical Utility: Reduces burden for adherence to high-intensity regimens; provides more precise feedback than traditional methods.

Augmented Reality (AR)

• Application: Treatment of 'phantom limb' pain in upper and lower limb amputees. • Mechanism: ◦ 'Phantom motor execution': Enabled via sophisticated machine-learning algorithms to decode signals. ◦ Retraining: Uses AR to retrain the brain's perception of missing limbs. • Comparison to Mirror Therapy: ◦ Mirror therapy: Patient moves healthy limb in front of a mirror → perceived movement of missing limb. ◦ AR Advantage: Can be based on movements of the affected limb (using the remaining portion) rather than the contralateral limb.

Neurofeedback

• Methodology: 1. Real-time fMRI data acquisition from scanner. 2. Image reconstruction of neural activity. 3. Mapping to 3D brain map (highlighting active regions). 4. Translation to feedback display (e.g., a thermometer icon). 5. Patient task: Attempt to change the display → learn to consciously modulate own brain activity. • Clinical Targets: ◦ Chronic pain, Parkinson's disease, epilepsy, and ADHD.

Noninvasive Brain Stimulation (NIBS)

• Transcranial Magnetic Stimulation (TMS): ◦ Mechanism: Coils generate magnetic fields → induce electrical fields in the cortical tissue. • Transcranial Direct Current Stimulation (tDCS): ◦ Mechanism: Electrical current flows from the anode (+) to the cathode (–) through superficial cortical areas → polarization.

Brain-Machine Interfaces (BMI)

• Target Population: 'Locked-in' patients with advanced ALS. • Mechanism: 1. Implanted electrodes on the motor cortex. 2. Signal transmission via an implanted transmitter. 3. Wireless transmission via antenna and receiver. 4. Real-time translation of neural patterns into device control (e.g., a tablet). • Clinical Goal: Bypass damaged motor pathways where signals to muscles are disrupted but the brain remains intact.

KEY PEARLS & HIGH-YIELD POINTS

• Plasticity: The brain remains highly plastic regardless of age or ongoing injury/degeneration. • Robotics: Key benefits include high-intensity training, quantification of kinematics, and antigravity support for weak limbs. • AR vs. Mirror Therapy: AR is unique because it can utilize the remaining portion of the affected limb rather than the contralateral limb. • NIBS Distinction: TMS uses magnetic fields to induce electrical fields; tDCS uses low-level constant current from anode (+) to cathode (–) for polarization.